Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Health Canada Trails 300 participants…

<< Previous

Bullboard Posts

Next >>

Comment by Mole101on Sep 20, 2021 1:28am

300 Views

Post# 33885433

RE:RE:RE:Health Canada Trails 300 participants…

Sep 17, 2021 - in Pediatric Emergency Departments ID NOW COVID-19 The Governors of the University of Calgary 2021-09-03 NCT05040763 ITA #329700 Authorized under Clinical Trials Interim Order POC Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2 Virus in Human Saliva COVID-19 Rapid Antigen Test Therma Bright Inc. 2021-09-16

Mole101 wrote:

Finally approved to go ahead as of the 16/09/2021

Show entries

Trial Name /Protocol #/control # Title Medical device name Authorization holder Authorization date Clinicaltrials.gov Link

ITA #329700
Authorized under Clinical Trials Interim Order
POC Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2 Virus in Human Saliva COVID-19 Rapid Antigen Test Therma Bright Inc. 2021-09-16

Dude51 wrote: Old News?

Study Type : Observational

Estimated Enrollment : 300 participants

Observational Model: Cohort

Time Perspective: Retrospective

Official Title: POC Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2 Virus in Human Saliva

Estimated Study Start Date : May 15, 2021

Estimated Primary Completion Date : June 30, 2021

Estimated Study Completion Date : June 30, 2021

Trial Name /Protocol #/control #	Title	Medical device name	Authorization holder	Authorization date	Clinicaltrials.gov Link
ITA #329700 Authorized under Clinical Trials Interim Order	POC Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2 Virus in Human Saliva	COVID-19 Rapid Antigen Test	Therma Bright Inc.	2021-09-16